Ibnsina Pharma Statistics

Total Valuation

Ibnsina Pharma has a market cap or net worth of EGP 11.40 billion. The enterprise value is 17.64 billion.

Market Cap	11.40B
Enterprise Value	17.64B

Important Dates

The last earnings date was Wednesday, February 25, 2026.

Earnings Date	Feb 25, 2026
Ex-Dividend Date	Oct 13, 2025

Share Statistics

Ibnsina Pharma has 1.01 billion shares outstanding. The number of shares has decreased by -0.13% in one year.

Current Share Class	1.01B
Shares Outstanding	1.01B
Shares Change (YoY)	-0.13%
Shares Change (QoQ)	+97.07%
Owned by Insiders (%)	26.01%
Owned by Institutions (%)	24.14%
Float	652.98M

Valuation Ratios

The trailing PE ratio is 14.88 and the forward PE ratio is 8.32.

PE Ratio	14.88
Forward PE	8.32
PS Ratio	0.15
PB Ratio	4.09
P/TBV Ratio	4.47
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.45, with an EV/FCF ratio of -21.89.

EV / Earnings	18.53
EV / Sales	0.23
EV / EBITDA	4.45
EV / EBIT	4.88
EV / FCF	-21.89

Financial Position

The company has a current ratio of 1.03, with a Debt / Equity ratio of 2.59.

Current Ratio	1.03
Quick Ratio	0.75
Debt / Equity	2.59
Debt / EBITDA	1.82
Debt / FCF	-8.95
Interest Coverage	1.41

Financial Efficiency

Return on equity (ROE) is 39.54% and return on invested capital (ROIC) is 18.17%.

Return on Equity (ROE)	39.54%
Return on Assets (ROA)	6.96%
Return on Invested Capital (ROIC)	18.17%
Return on Capital Employed (ROCE)	80.64%
Weighted Average Cost of Capital (WACC)	16.74%
Revenue Per Employee	13.93M
Profits Per Employee	173,088
Employee Count	5,500
Asset Turnover	2.36
Inventory Turnover	9.47

Taxes

In the past 12 months, Ibnsina Pharma has paid 125.36 million in taxes.

Income Tax	125.36M
Effective Tax Rate	11.64%

Stock Price Statistics

The stock price has increased by +68.83% in the last 52 weeks. The beta is 0.59, so Ibnsina Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.59
52-Week Price Change	+68.83%
50-Day Moving Average	11.50
200-Day Moving Average	10.66
Relative Strength Index (RSI)	47.36
Average Volume (20 Days)	8,679,833

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ibnsina Pharma had revenue of EGP 76.60 billion and earned 951.98 million in profits. Earnings per share was 0.76.

Revenue	76.60B
Gross Profit	6.45B
Operating Income	3.61B
Pretax Income	1.08B
Net Income	951.98M
EBITDA	3.81B
EBIT	3.61B
Earnings Per Share (EPS)	0.76

Full Income Statement

Balance Sheet

The company has 975.19 million in cash and 7.21 billion in debt, giving a net cash position of -6.24 billion or -6.19 per share.

Cash & Cash Equivalents	975.19M
Total Debt	7.21B
Net Cash	-6.24B
Net Cash Per Share	-6.19
Equity (Book Value)	2.78B
Book Value Per Share	1.40
Working Capital	794.75M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -71.06 million and capital expenditures -734.60 million, giving a free cash flow of -805.66 million.

Operating Cash Flow	-71.06M
Capital Expenditures	-734.60M
Free Cash Flow	-805.66M
FCF Per Share	-0.80

Full Cash Flow Statement

Margins

Gross margin is 8.42%, with operating and profit margins of 4.72% and 1.24%.

Gross Margin	8.42%
Operating Margin	4.72%
Pretax Margin	1.41%
Profit Margin	1.24%
EBITDA Margin	4.98%
EBIT Margin	4.72%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.16, which amounts to a dividend yield of 1.38%.

Dividend Per Share	0.16
Dividend Yield	1.38%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	4
Payout Ratio	21.12%
Buyback Yield	0.13%
Shareholder Yield	1.51%
Earnings Yield	8.35%
FCF Yield	-7.07%

Dividend Details

Stock Splits

The last stock split was on June 1, 2022. It was a forward split with a ratio of 1.16666.

Last Split Date	Jun 1, 2022
Split Type	Forward
Split Ratio	1.16666

Scores

Altman Z-Score	n/a
Piotroski F-Score	3